More than 1,000 incarcerated people died from hepatitis C-related complications in the six years after a cure hit the market. Sponsored by Hundreds of incarcerated people are dying of hep C — even though we have a simple cure By Nicholas Florko Nicholas Florko/STAT More than 1,000 incarcerated people died from hepatitis C-related complications in the six years after a cure hit the market. Read More Legal and medical experts say denying hepatitis C care is cruel and unusual punishment, but the courts are still catching up By Nicholas Florko Courtesy Fontaine family Legal and medical experts say denying hepatitis C care is cruel and unusual punishment. But the courts are still catching up. Read More STAT+: AbbVie exits major pharmaceutical industry lobbying groups By Rachel Cohrs and Sarah Owermohle Ruby Wallau for STAT The maker of one of the world’s most profitable medicines is exiting the pharma industry’s two major lobbying organizations next year. Read More Sponsored Insight by NOVAVAX How is Novavax working to address COVID-19? With 10+ years of vaccine technology Novavax is focused on developing investigational vaccines for diseases like COVID-19 and the seasonal flu. Learn more. STAT+: Chief health equity officers are growing more common. But experts say companies need to empower them By Mohana Ravindranath Adobe A string of high-profile health companies like Teladoc and CVSHealth have hired their first chief health equity officers this year. Read More Listen: Leaky health data, ASH22, & what it takes to get booed by your peers By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT's Katie Palmer joins us to explain how telehealth is putting sensitive patient information into the hands of big tech firms. Read More STAT+: Biden administration takes aim at Medicare Advantage care denials, misleading ads By Tara Bannow Pablo Martinez Monsivais/AP The Biden administration has big plans for reforming Medicare Advantage in 2024. The biggest targets: care denials and scammy advertisements. Read More Thursday, December 15, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments